Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2008-05-27
2008-05-27
Mondesi, Robert B. (Department: 1652)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Reexamination Certificate
active
07378500
ABSTRACT:
Disclosed is a method of promoting healing of a chronic dermal skin ulcer, such as a diabetic ulcer, on a subject. The method comprises the step of contacting the chronic dermal skin ulcer with an effective amount of an agonist of the non-proteolytically activated thrombin receptor.
REFERENCES:
patent: 5352664 (1994-10-01), Carney et al.
patent: 5500412 (1996-03-01), Carney et al.
patent: WO 88/03151 (1988-05-01), None
patent: WO 96/40033 (1996-12-01), None
patent: WO 01/49309 (2001-07-01), None
HGS, Backgounder, Internet Publication, Sep. 2000, pp. 1-3.
Stiernberg, J., et al., “Acceleration of full-thickness wound healing in normal rats by the synthetic thrombin peptide, TP508,”Wound Repair and Regeneration, 8(3):204-215 (2000).
Norfleet, A.M., et al., “Thrombin peptide, TP508, stimulates angiogenic responses in animal models of dermal wound healing, in chick chorioallantoic membranes, and in cultured human aortic and microvascular endothelial cells,”General Pharmacology, 35:249-254 (2002).
Norfleet, A.M., et al., “Thrombin peptide TP508 accelerates closure of dermal excisions in animal tissue with surgically induced ischemia,”Wound Repair and Regeneration, 8(6):517-529 (2000).
Pernia, S.D., et al., “A Synthetic Peptide Representing the Thrombin Receptor-Binding Domain Enhances Wound Closure In Vivo,”SAAS Bulletin: Biochem.&Biotech., 3:8-12 (1990).
Carney, Darrell H., “Postclotting Cellular Effects of Thrombin Mediated by Interaction with High-Affinity Thrombin Receptors,” InThrombin Structure and Function, Berliner, L.J. (ed.)(New York: Plenum Press), pp. 351-396 (1992).
Stiernberg, J., et al., “The Role of Thrombin and Thrombin Receptor Activating Peptide (TRAP-508) in Initiation of Tissue Repair,”Thrombosis and Haemostasis, 70(1)158-162 (1993).
Carney, D.H., et al., “Enhancement of Incisional Wound Healing and Neovascularization in Normal Rats by Thrombin and Synthetic Thrombin Receptor-activating Peptides,”J. Clin. Invest., 89:1469-1477 (1992).
Carney, D.H., et al., “Role of High-Affinity Thrombin Receptors in Postclotting Cellular Effects of Thrombin,”Seminars in Thrombosis and Hemostasis, 18(1):91-102 (1992).
Glenn, K.C., et al., “Synthetic Peptides Bind to High-Affinity Thrombin Receptors and Modulate Thrombin Mitogenesis,”Peptide Research, 1(2):65-73 (1988).
Sower, L.E., et al., “Thrombin Peptide, TP508, Induces Differential Gene Expression in Fibroblasts through a Nonproteolytic Activation Pathway,”Experimental Cell Research, 247:422-431 (1999).
Steed, D.L., et al., “Promotion and Acceleration of Diabetic Ulcer Healing by Arginine-Glycine-Aspartic Acid (RGD) Peptide Matrix,”Diabetes Care, 18(1):39-46 (1995).
Press Release: Chrysalis BioTechnology to begin clinical trials, (Sep, 24, 1998).
Press Release: Chrysalis Announces Completion of Pilot Chrysalin® Clinical Trial for Diabetic Ulcers, (Aug. 21, 2001).
Hollenberg, Morley D., et al., “Synergistic Actions of a Thrombin-Derived Synthetic Peptide and a Thrombin Receptor-Activating Peptide in Stimulating Fibroblast Mitogenesis,”J. Cell Physiol. 169:491-496 (1996).
Hamilton Brook Smith & Reynolds P.C.
Mondesi Robert B.
OrthoLogic Corp.
LandOfFree
Use of thrombin-derived peptides for the therapy of chronic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of thrombin-derived peptides for the therapy of chronic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of thrombin-derived peptides for the therapy of chronic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2768791